Theratechnologies, Inc. (THTX)
3.39
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Theratechnologies Shareholders Equity (Quarterly) : -27.92M for May 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2025 | -27.92M |
| February 28, 2025 | -24.47M |
| November 30, 2024 | -25.27M |
| August 31, 2024 | -19.68M |
| May 31, 2024 | -23.21M |
| February 29, 2024 | -24.60M |
| November 30, 2023 | -20.87M |
| August 31, 2023 | -41.70M |
| May 31, 2023 | -41.53M |
| February 28, 2023 | -32.31M |
| November 30, 2022 | -22.57M |
| August 31, 2022 | -18.06M |
| May 31, 2022 | -11.64M |
| February 28, 2022 | 10.16M |
| November 30, 2021 | 17.76M |
| August 31, 2021 | 26.87M |
| May 31, 2021 | 35.16M |
| February 28, 2021 | 40.40M |
| November 30, 2020 | 3.224M |
| August 31, 2020 | 8.526M |
| May 31, 2020 | 15.42M |
| February 29, 2020 | 20.66M |
| November 30, 2019 | 24.83M |
| August 31, 2019 | 30.02M |
| May 31, 2019 | 31.36M |
| Date | Value |
|---|---|
| February 28, 2019 | 34.12M |
| November 30, 2018 | 35.02M |
| August 31, 2018 | 35.55M |
| May 31, 2018 | 30.22M |
| February 28, 2018 | 31.55M |
| November 30, 2017 | 33.47M |
| August 31, 2017 | 36.42M |
| May 31, 2017 | 33.45M |
| February 28, 2017 | 30.10M |
| November 30, 2016 | 20.00M |
| August 31, 2016 | 19.67M |
| May 31, 2016 | 18.83M |
| February 29, 2016 | 14.90M |
| November 30, 2015 | 15.04M |
| August 31, 2015 | 14.43M |
| May 31, 2015 | 6.730M |
| February 28, 2015 | 6.083M |
| November 30, 2014 | 6.900M |
| August 31, 2014 | 10.59M |
| May 31, 2014 | 14.65M |
| February 28, 2014 | 13.52M |
| November 30, 2013 | 17.50M |
| August 31, 2013 | 20.01M |
| May 31, 2013 | 22.33M |
| February 28, 2013 | 23.88M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Psyence Biomedical Ltd. | 11.87M |
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| enGene Therapeutics, Inc. | 230.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.27M |
| Total Liabilities (Quarterly) | 79.19M |